Specifar Pharmaceuticals S.A. - Ownership and Business Overview

Life ScienceCompany

Specifar Pharmaceuticals S.A. Ownership

Who owns Specifar Pharmaceuticals S.A.?

Specifar Pharmaceuticals S.A. is owned by Allergan. It was acquired on May 25, 2011.

Specifar Pharmaceuticals S.A. Business Overview

Where is Specifar Pharmaceuticals S.A. headquartered?

Specifar Pharmaceuticals S.A. is headquartered in Athens, Greece.

How many employees does Specifar Pharmaceuticals S.A. have?

Specifar Pharmaceuticals S.A. has 460 employees.

What sector is Specifar Pharmaceuticals S.A. in?

Specifar Pharmaceuticals S.A. is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Specifar Pharmaceuticals S.A.

1, 28 Octovriou Street,
Athens,
Greece,
30 210 54 01 500
www.specifar.gr

Specifar is a multinational generic pharmaceuticals company with its headquarters in Greece and representative offices in Europe. Specializing in development, production, distribution and sales & marketing, Specifar commits to delivering high-quality and affordable medicines to patients and its customers. Specifar employs approximately 460 people worldwide and has obtained more than 600 Marketing Authorizations in Europe, South Africa, Canada, the Middle East and Asia.


Company Summary

SECTOR

Life Science

Employees

460

Subsidiary of

Allergan

 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Specifar Pharmaceuticals S.A.

Life Science Companies , Greece Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Greece Companies

Largest Greece Companies , Acquisitive Greece Companies , Recently Acquired Greece Companies , Recently Sold Greece Companies , Private Greece Companies , Public Greece Companies , Acquired Greece Companies , PE Backed Greece Companies
Mergr

Product

Company

Legal